Johns Hopkins neurologist Elisabeth Marsh discusses the under recognized deficits of stroke recovery and the work she is doing to understand the brain pathophysiology of those deficits, as well as possible therapeutic targets that to help with recovery.
Johns Hopkins Medicine researchers have found a possible window of opportunity during ALS treatment to target astrocyte abnormalities — a subtype of cells in the central nervous system that provide a structure to metabolically support ...
Johns Hopkins neurosurgeon-scientists test a gamut of new therapeutic approaches — such as using bioengineered cancer cells to produce neoantigens that activate immune response. They simultaneously develop new tools and techniques to improve quality of life.
Spine neurosurgeons use technologies co-developed by faculty members to advance patient care. Plus, a first-of-its-kind lab creates a new class of implantable, wearable medical devices to aid those with spinal cord injuries.